| Single Dose Group [n = 225] | Double Dose Group [n = 225] | P | RR (95%CI) | NNT(Harm) (95%CI) |
Noncompliance | 29 (12.9%) | 48 (21.3%) | 0.02 | 1.66 (1.09 - 2.53) | 11.8 (65.4 - 6.51) |
Nausea/Vomiting | 7 (3.11%) | 11 (4.89%) | 0.34 | 1.57 (0.62 - 3.98) | – |
Constipation | 24 (10.7%) | 41 (18.2%) | 0.03 | 1.71 (1.07 - 2.73) | 13.2 (91.1(Harm) - 7.13(Harm)) |
Abdominal pain | 9 (4.0%) | 14 (6.2%) | 0.29 | 1.56 (0.68 - 3.52) | – |
Black staining of the stools | 36 (16.0%) | 68(30.2%) | <0.001 | 1.89 (1.32 - 2.71) | 7.0 (15.2(Harm) - 4.56(Harm)) |